MTS Health Investors has announced it has sold portfolio company DNA Diagnostics Center (DDC) to GHO Capital Partners for $110 million.
DDC, based in Fairfield, Ohio, provides DNA testing services in three main areas: paternity and other family relationships, forensics and genetics.
MTS is a New York-based PE firm that invests in operating companies within services sectors of the healthcare industry. Investment targets are primarily U.S. companies with valuations of $25 million to $300 million.
GHO Capital Partners, or Global Healthcare Opportunities, is a London-based specialist healthcare investor.
